NCT02480374 2024-10-02Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian CancerImunonPhase 1 Completed18 enrolled
NCT00473954 2013-03-26Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian CancerEGEN, Inc.Phase 1 Completed13 enrolled
NCT00137865 2013-02-28Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian CancerEGEN, Inc.Phase 1 Terminated18 enrolled